The receptor for advanced glycation end products promotes bacterial growth at distant body sites in Staphylococcus aureus skin infection

Microbes and Infection

Volumn 17, Issue 9, 2015, Pages 622-627

  Achouiti, Ahmed ^a   van't Veer, Cornelis ^a   de Vos, Alex F ^a   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Innate immunity; Receptor for advanced glycation endproducts; Skin infection; Staphylococcus aureus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL LOAD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; HOST RESISTANCE; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; WILD TYPE; ANIMAL; BACTEREMIA; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; NEUTROPHIL;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BACTEREMIA; CYTOKINES; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; LIVER; LUNG; MICE; MICE, KNOCKOUT; NEUTROPHILS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 84940450265     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2015.06.002     Document Type: Article

References (28)

1. Achouiti A., de Vos A.F., de Beer R., Florquin S., van 't Veer C., van der Poll T. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia. J Innate Immun 2013, 5:603-612.
2. Achouiti A., van der Meer A.J., Florquin S., Yang H., Tracey K.J., van 't Veer C., et al. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia. Crit Care 2013, 17:R296.
3. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med Berl 2005, 83:876-886.
4. Bunce C., Wheeler L., Reed G., Musser J., Barg N. Murine model of cutaneous infection with gram-positive cocci. Infect Immun 1992, 60:2636-2640.
5. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009, 7:629-641.
6. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003, 198:1507-1515.
7. Cho J.S., Guo Y., Ramos R.I., Hebroni F., Plaisier S.B., Xuan C., et al. Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog 2012, 8:e1003047.
8. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., et al. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
9. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23:616-687.
10. Frommhold D., Kamphues A., Hepper I., Pruenster M., Lukic I.K., Socher I., et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 2010, 116:841-849.
11. Gebhardt C., Riehl A., Durchdewald M., Németh J., Fürstenberger G., Müller-Decker K., et al. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008, 205:275-285.
12. Kierdorf K., Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol 2013, 94:55-68.
13. Krishna S., Miller L.S. Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol 2012, 34:261-280.
14. Leibold J.S., Riehl A., Hettinger J., Durben M., Hess J., Angel P. Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo. J Investig Dermatol 2013, 133:2400-2406.
15. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113:1641-1650.
16. Lohwasser C., Neureiter D., Weigle B., Kirchner T., Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 2006, 126:291-299.
17. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
18. Miller L.S., Cho J.S. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011, 11:505-518.
19. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
20. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat Rev Immunol 2009, 9:679-691.
21. Ramsgaard L., Englert J.M., Manni M.L., Milutinovic P.S., Gefter J., Tobolewski J., et al. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One 2011, 6:e20132.
22. Sethi S., Chakraborty T. Role of TLR-/NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection. Virulence 2011, 2:316-328.
23. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388.
24. van Zoelen M.A., Achouiti A., van der Poll T. The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care 2011, 15:208.
25. van Zoelen M.A., Schmidt A.M., Florquin S., Meijers J.C., de Beer R., de Vos A.F., et al. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J Infect Dis 2009, 200:765-773.
26. van Zoelen M.A., Schouten M., de Vos A.F., Florquin S., Meijers J.C., Nawroth P.P., et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009, 182:4349-4356.
27. Wieland C.W., van Lieshout M.H., Hoogendijk A.J., van der Poll T. Host defence during Klebsiella pneumonia relies on haematopoietic-expressed toll-like receptors 4 and 2. Eur Respir J 2011, 37:848-857.
28. Yamamoto Y., Harashima A., Saito H., Tsuneyama K., Munesue S., Motoyoshi S., et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 2011, 186:3248-3257.